Alisa B. Busch, MD, MS

home / authors / alisa-b-busch-md-ms

Articles

October 5th 2022

The Impact of HDHPs on Service Use and Spending for Substance Use Disorders

Matthew D. Eisenberg, PhD Alene Kennedy-Hendricks, PhD Cameron Schilling, MPH Alisa B. Busch, MD, MS Haiden A. Huskamp, PhD Elizabeth A. Stuart, PhD Mark K. Meiselbach, PhD Colleen L. Barry, PhD, MPP

Offering a high-deductible health plan (HDHP) led to a 6.6% reduction in the probability of using substance use disorder services and a shift in spending from the plan to the enrollee.

June 16th 2020

Effect of High-Deductible Insurance on Health Care Use in Bipolar Disorder

J. Frank Wharam, MD, MPH Alisa B. Busch, MD, MS Jeanne Madden, PhD Fang Zhang, PhD Matthew Callahan, MS Robert F. LeCates, MA Phyllis Foxworth, BS Stephen Soumerai, ScD Dennis Ross-Degnan, ScD Christine Y. Lu, PhD

High-deductible health plan members with bipolar disorder experienced a reduction in nonpsychiatrist mental health provider visits but no changes in other utilization.

January 20th 2016

The Introduction of Generic Risperidone in Medicare Part D

Vicki Fung, PhD Mary Price, MA Alisa B. Busch, MD, MS Mary Beth Landrum, PhD Bruce Fireman, MA Andrew A. Nierenberg, MD Joseph P. Newhouse, PhD John Hsu, MD, MBA, MSCE

This study examines the plan characteristics associated with generic risperidone use and spending and adherence outcomes associated with use among Medicare Advantage Part D beneficiaries.